Publications by authors named "Thomas Waerner"

Claim this Profile
H
Host Cell Protein Clinical Safety Risk Assessment-An Updated Industry Review.
Lisette Coye, Marisa A Jones, Georgeen Gaza-Bulseco, Carmelata Chitikila, Severine Clavier, Thomas Waerner

Biotechnol Bioeng· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.
Marius Nicolaus Felix, Thomas Waerner, Daniel Lakatos, Bernd Reisinger, Simon Fischer

Front Bioeng Biotechnol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination.
Daniel M Waldera-Lupa, Yvonne Jasper, Pia Köhne, Ronja Schwichtenhövel, Heiner Falkenberg, Thomas Waerner

MAbs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"High-risk" host cell proteins (HCPs): A multi-company collaborative view.
Marisa Jones, Nisha Palackal, Fengqiang Wang, Georgeen Gaza-Bulseco, Karen Hurkmans, Thomas Waerner

Biotechnol Bioeng· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products.
Heiner Falkenberg, Daniel Michael Waldera-Lupa, Martin Vanderlaan, Thomas Schwab, Kurt Krapfenbauer, Thomas Waerner

Biotechnol Prog· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with host cell protein impurities in biopharmaceuticals.
Martin Vanderlaan, Judith Zhu-Shimoni, Sansan Lin, Feny Gunawan, Thomas Waerner

Biotechnol Prog· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine.
Thomas Waerner, Dietmar Thurnher, Kurt Krapfenbauer

EPMA J· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis.
Philipp Schähs, Petra Weidinger, Olivia C Probst, Barbara Svoboda, Johannes Stadlmann, Thomas Waerner

Exp Cell Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A receptor-binding-based bioassay to determine the potency of a plasmid biopharmaceutical encoding VEGF-C.
Thomas Waerner, Thomas Girsch, Sandra Varga, Lichun Huang, Alexander Gornikiewicz

Anal Bioanal Chem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.
Thomas Waerner, Memetcan Alacakaptan, Ido Tamir, Rupert Oberauer, Annamaria Gal

Cancer Cell· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression profiling of epithelial plasticity in tumor progression.
Martin Jechlinger, Stefan Grunert, Ido H Tamir, Elzbieta Janda, Susanna Lüdemann, Thomas Waerner

Oncogene· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis